Skip to main content

Peer Review reports

From: Immunogenicity, efficacy, and safety of SARS-CoV-2 vaccine dose fractionation: a systematic review and meta-analysis

Original Submission
6 Jul 2022 Submitted Original manuscript
12 Aug 2022 Reviewed Reviewer Report - Sung-mok Jung
16 Aug 2022 Reviewed Reviewer Report
18 Aug 2022 Reviewed Reviewer Report
11 Sep 2022 Author responded Author comments - Bingyi Yang
Resubmission - Version 2
11 Sep 2022 Submitted Manuscript version 2
12 Sep 2022 Reviewed Reviewer Report
25 Sep 2022 Reviewed Reviewer Report - Sung-mok Jung
6 Oct 2022 Author responded Author comments - Bingyi Yang
Resubmission - Version 3
6 Oct 2022 Submitted Manuscript version 3
7 Oct 2022 Author responded Author comments - Bingyi Yang
Resubmission - Version 4
7 Oct 2022 Submitted Manuscript version 4
Publishing
10 Oct 2022 Editorially accepted
25 Oct 2022 Article published 10.1186/s12916-022-02600-0

You can find further information about peer review here.

Back to article page